February 21, 2017 / 3:05 PM / 6 months ago

BRIEF-Eurocine Vaccines: vaccine candidate Immunose FLU shows good safety in clinical study

Feb 21 (Reuters) - Eurocine Vaccines AB:

* Immunose FLU, a quadrivalent influenza vaccine candidate showed good safety in a clinical phase I/II study

* Immunological results from the study are expected in Q3 2017

Source text: bit.ly/2kV92wP

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below